GENE ONLINE|News &
Opinion
Blog

CDMO
GeneOnline’s Weekly News Highlights: Nov 13-Nov 17
2023-11-20
Japan’s Red Biotechnology and International Business Partnering Take Spotlight on BioJapan 2023
2023-11-03
Taiwan’s Biotech Brilliance Shines at BIO 2023: Unveiling Cutting-Edge Discoveries and Strategic Partnerships
2023-06-20
Bora and Celltrion Join Forces To Distribute Oral Drugs Across APAC
2023-04-07
Forge Biologics Raises $90 Million To Expand Gene Therapy CDMO
2022-09-14
Scaling up Korea’s Biotech Presence in The Global Value Chain, an Interview with Seung Kyou Lee, Vice President of KoreaBIO
2022-08-31
Catalent Scoops Up Fellow CDMO, Metrics, for $475 Million
2022-08-11
WuXi Biologics Adds Microbial Fermentation to CDMO Offering in Hangzhou
2022-07-05
Novartis and Samsung Biologics Sign Low-Profile $81 Million Deal
2022-06-10
Lonza Signs CDMO Deal to Break Into Israeli Market
2022-05-25
LOTTE Corporation Buys Bristol Myers Squibb’s New York Manufacturing Plant for $160 Million
2022-05-16
Bora Pharmaceuticals Expands with Eden Biologics’ CDMO Purchase
2022-05-11
Asahi Kasei Medical Ups CDMO Business in the US with Bionova Buy
2022-04-21
HCmed and Formosa Laboratories Join Forces to Create CDMO for Inhaled Drugs
2022-03-08
AbClon, HK inno.N Collaborates to Take On Novartis’ CAR T-Cell Therapy
2022-02-15
1 2 3
LATEST
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
2023-11-27
SK Bioscience and Hilleman Laboratories Join Forces for Ebola Vaccine Development
2023-11-23
BeiGene to Expand Oncology Pipeline Through ENSEM Therapeutics Partnership
2023-11-23
Advancing the Frontiers of Cell and Gene Therapy – An Interview with Dr. Shin Kawamata
2023-11-21
Astellas and Pfizer’s Drug Receives FDA Approval as Treatment for High-Risk Prostate Cancer Recurrence
2023-11-21
Singapore’s NUS Medicine Launches Centre for Sustainable Medicine
2023-11-20
Pioneering Partnership: Africa CDC and China CDC Elevate Public Health Initiatives
2023-11-20
EVENT
2023-11-30
2023 Healthcare+ EXPO・Taiwan
Taipei , Taiwan
Scroll to Top